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that this has been a major constraint on
progress in the assessment of the various
forms of treatment. The difficulty ofdeciding
what is and what is not a cancer remains and
the chapter on the clinico-histopathologic
evaluation of prostatic cancer competently
tackles this question. Even here however one
wonders whether some of the examples
described as cancer are not in fact variants of
normal, functional prostatic acini.
These are, however, small criticisms in a
book which provides admirable coverage of
the subject in the manner of a series of over-
views. It will appeal to specialists in urology
and to clinical co-workers who participate
in the management of this disease. It will
also have an appeal for laboratory and
research workers who are involved in its
study. The book is well produced and well
edited, each chapter having its own biblio-
graphy, and there is an enjoyable summari-
zation of the book contents by the editor as
a concluding chapter.
N. J. BLACKLOCK
The Practice of Cancer Surgery. Eds.
A. E. ALFONSO & B. GARDNER (1982).
Hemel Hempstead: Prentice Hall. 477 pp.
£31.90 net.
This book provides brief accounts of cell
kinetics, cancer chemotherapy, radiotherapy,
tumour immunotherapy and pathology. The
surgery of cancer at various primary sites is
then described. The professed aim is to
provide "a fundamental practical guideline
outlining current basic principles in the
surgical management of cancer patients".
The result is disappointing. Different
contributors have placed quite different
emphasis on principles of diagnosis, treat-
ment and results. The suggested staging
methods for breast cancer are too detailed to
be of practical value, eleven pages are
devoted to the operations for carcinoma of
the stomach, but urinary diversion, following
total cystectomy, is dismissed in two lines
and the possible postoperative problems are
not mentioned. The legend for Fig. 18.1
needs correction. The book cannot be
recommended to undergraduates or post-
graduates reading for the FRCS diploma
and practising surgeons will find little to
enlighten them.
L. TURNER
Hormone Therapy. Ed. B. J. A. FURR
(1982). London: W. B. Saunders Company
Ltd. 312 pp. £10.75 net.
This issue of Clinics in Oncology "aims to
review the existing approaches to therapy of
hormone responsive tumours and to high-
light current problems and controversy". In
a thoughful opening chapter, Stoll considers
the mechanisms of hormonally-induced re-
gression, the heterogeneity of hormone-
dependent tumours and the stringent
criteria by which we judge response. In the
latter context, it is important to be aware
that the survival times of patients whose
disease shows no change on treatment is
similar to partial responders. Stoll also
emphasis that hormone-dependent tumours
are often slow to respond and these are then
often slow to progress and that we should be
aware of too hurried evaluation of disease
status. Jordan gives an excellent concise
review, including the limitations of animal
models of hormone-dependent cancer.
The prostate is represented by a review of
the mechanism of action and clinical use of
the anti-androgens cyproterone acetate and
flutamide. These compounds are discussed
again in an overview of hormone therapy of
prostate carcinoma.
The breast is covered by a concise review
of anti-oestrogens by Manni and Pearson and
an excellent extensive review of aromatase
inhibitors by Santen and Brodie. The book
is worth acquiring for the latter article
alone. De Sombre covers steroid receptors
and Forbes was given the unenviable task
ofreviewing the whole ofendocrine therapy in
breast cancer. Because of the repetition of
data discussed in other chapters, and the
necessarily superficial treatment, an in-
depthreview oftheuse ofprogesterones would
perhaps have been more appropriate. There
are other chapters on endometrial carcinoma,
lymphoma and leukaemia, thyroid carcinoma
and pituitary adenomas. The final chapter is
a review by the Editor, B. J. A. Furr, on
future prospects for hormone therapy, partic-
ularly the use of LHRH analogues and anti-
oestrogens with less agonist activity. He
emphasises the need for us to know more
about growth factors and the importance of
the extracellular matrix, two very important
areas for research in the next decade.
This book has some excellent chapters and
can be recommended to those interested in